Read + Share
Amedeo Smart
Independent Medical Education
Ynalvez LA, Deswal A. In adults with HF with preserved ejection fraction and obesity, tirzepatide reduced a composite of CV death or worsening HF at 2 y. Ann Intern Med 2025;178:JC43.PMID: 40163881
Email
LinkedIn
Privacy Policy